Genomma Lab Internacional, S.A.B. de C.V.
GNMLF
$1.43
$0.169913.48%
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 2.43% | -10.95% | -11.55% | 15.11% | 12.29% |
| Total Depreciation and Amortization | 12.30% | 17.86% | 13.24% | 20.87% | 25.90% |
| Total Amortization of Deferred Charges | 116.45% | 116.45% | 116.45% | -29.93% | -29.93% |
| Total Other Non-Cash Items | 140.19% | 45.72% | -28.00% | -59.00% | -56.99% |
| Change in Net Operating Assets | -42.71% | 71.19% | 300.25% | -72.85% | -724.29% |
| Cash from Operations | 27.42% | 50.93% | 26.00% | -16.02% | -36.12% |
| Capital Expenditure | 45.73% | 40.45% | 33.40% | 14.53% | 17.32% |
| Sale of Property, Plant, and Equipment | -53.22% | -27.27% | -29.25% | -139.68% | 396.42% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -421.41% | -10.65% | 21.09% | 130.94% | 45.07% |
| Cash from Investing | -9.37% | 31.50% | 30.80% | 21.00% | 25.91% |
| Total Debt Issued | -44.84% | 26.71% | 27.33% | 364.67% | 281.33% |
| Total Debt Repaid | 37.88% | -46.57% | -45.25% | -117.18% | -139.47% |
| Issuance of Common Stock | 294.87% | 279.34% | 279.34% | 571.58% | 512.68% |
| Repurchase of Common Stock | -111.94% | -107.53% | -95.95% | -38.65% | -207.54% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -49.60% | -13.99% | 14.87% | -8.96% | 20.56% |
| Other Financing Activities | 9.65% | -30.58% | -59.42% | -1,365.70% | -254.59% |
| Cash from Financing | -71.11% | -55.16% | -41.40% | 65.97% | 45.26% |
| Foreign Exchange rate Adjustments | 137.96% | 96.48% | 51.11% | -105.36% | -179.65% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -14.92% | 82.17% | 666.34% | 182.33% | -33.78% |
